CSTL Castle Biosciences, Inc.

$32.33▲ +0.03% Healthcare Other
After hours $32.33▲ +0.00% Sep 11, 7:30 PM ET
Volume 224.2K Avg Volume (10D) 258.3K
Key Metrics & Fundamentals
Market Cap
$987.67M
P/E Ratio
–
Div Yield
–%
52W Range
17.72 - 44.28
% vs 50 MA
11.63%
% vs 200 MA
10.12%
RSI-14
54.6
MACD Histogram
-0.4200
Beta (1Y vs SPY)
0.92
Free Cash Flow
$6.55M
Gross Rev
$103.55M
Gross Profit
$79.85M
EBITDA
$3.20M
COGS
$23.70M
Operating Exp
$82.92M
Operating Income
-$3.07M
EBIT
-$3.07M
Pretax Income
-$1.69M
Net Income
-$2.06M
EPS (Diluted)
-0.07
Price & Volume History
Loading chart…
Recent News
JAAD Publication Shows Improved Performance of DecisionDx®-SCC
PR Newswire · Sep 9, 2026 8:30 PM
Castle Biosciences, Inc. (CSTL) Is Up 15.46% in One Week: What You Should Know
Zacks · Aug 28, 2026 4:00 PM
Castle Biosciences (CSTL) Rallies On Earnings Optimism, Is The Stock Still Cheap?
Simply Wall St. · Aug 27, 2026 1:10 AM
Does Castle Biosciences (CSTL) Have the Potential to Rally 31.46% as Wall Street Analysts Expect?
Zacks · Aug 25, 2026 1:55 PM
Castle Biosciences to Participate in Upcoming Investor Conferences
PR Newswire · Aug 20, 2026 11:00 AM
Castle Biosciences Approved for Dual Listing on Nasdaq Texas
PR Newswire · Aug 17, 2026 11:00 AM
Castle Biosciences Raises Outlook as Melanoma, TissueCypher Tests Gain Traction
MarketBeat · Aug 13, 2026 5:01 AM
Castle Biosciences, Inc. Q2 2026 Earnings Call Summary
Moby · Jul 31, 2026 12:30 PM
Castle Biosciences Inc (CSTL) (Q2 2026) Earnings Call Highlights: Revenue Surges 20% to $103. ...
GuruFocus.com · Jul 31, 2026 5:03 AM
Castle Biosciences Q2 Earnings Call Highlights
MarketBeat · Jul 30, 2026 10:04 PM
Financial Overview - Income Statement Quarterly

See CSTL's money flow as a full page

Social Sentiment
Avg +0.05 · 2 posts
DDDiscussionI feel like more people should talk about this stock
r/investing · Aug 15, 2025
The author is long the stock and provides an analysis, indicating a positive sentiment.
positive +0.60
NewsDiscussionHealthtech stocks I should keep an eye on
r/investing · Dec 31, 2024
Negative sentiment due to the discontinuation of products and loss of coverage.
negative -0.50
AI Analysis

Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.

Not financial advice. All data, scores, charts, and analysis on this site are provided for informational and educational purposes only and do not constitute financial, investment, legal, or tax advice. Past performance is not indicative of future results. See our Legal Notice for full details.
An unhandled error has occurred. Reload 🗙